Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Qingyihuaji formula (QYHJ), confirmed efficacious in a series of clinical trials, has been applied to human pancreatic carcinoma treatment in Shanghai Cancer Center for years. Recent evidence highlighted that pluripotent stem cells transcription factor Nanog plays a pivotal role in carcinogenesis. H...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Evid Based Complement Alternat Med
Autors principals: Gao, Song, Pan, Yan, Song, Libin, Dong, Lei, Weng, Lao I., Wang, Peng, Hua, Yongqiang, Chen, Zhen, Liu, Luming
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086502/
https://ncbi.nlm.nih.gov/pubmed/27829864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7028289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars